Ittehad Chemicals Limited (ICL) reported net sales of approximately PKR 17.9 billion for the first nine months of FY24, reflecting a 3% decrease compared to the same period last year. Despite the decline in sales, the company’s cost reduction measures maintained a stable gross margin of 20% year-on-year. However, increased utility rates, higher taxation, and rising finance costs resulted in a 26% decrease in net profit, amounting to around PKR 977 million.
ICL has a diverse range of chemical products, including:
The company operates four major plants with the following annual capacities:
In FY23, the majority of ICL’s revenue came from Asia, totaling around PKR 21.1 billion. Additional sales were reported from other regions:
ICL’s total power requirement is 30 MW, with a power mix of 25% sourced from SNGPL (Sui Northern Gas Pipelines Limited) and 75% from RLNG (Regasified Liquefied Natural Gas).
The import price of LABSA stands at approximately USD 1600 per MT or around PKR 385,000 per MT. The company’s major export products include flakes, calcium chloride, and LABSA. To boost export volumes, ICL is actively negotiating with clients from the MENA region, Europe, and Central Asia.
ICL plans to expand its production capacity by introducing three new plants:
Disclaimer:
The information in this article is based on research by Taurus Research. All efforts have been made to ensure the data represented in this article is as per the research report. This report should not be considered investment advice. Readers are encouraged to consult a qualified financial advisor before making any investment decisions.
TRG Pakistan Limited (TRG), through its associate TRG International, holds significant stakes in two key…
Headline inflation is expected to reach approximately 12.66% in June 2024, compared to 11.76% in…
Pakistan Aluminium Beverage Cans Limited (PABC) has announced that it achieves AA- long term rating.
the average industry Gross Refining Margin (GRM) is expected to be around $3.8 per barrel.
Unity Foods Limited (UNITY) reported a transaction by a non-executive director.
The research house has raised its Dec 24 SRVI target price to Rs. 1438 per…